Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Diagnostics and Medical Technology›Cytodiagnosis

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Cytodiagnosis

Diagnostics and Medical Technology · NLM MeSH · updated 2026-11-04 · version 1

Citations verified against PubMedNot yet clinician-reviewed9 referencesApproximately 4 min read

Diagnosis of the type and, when feasible, the cause of a pathologic process by means of microscopic study of cells in an exudate or other form of body fluid.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 3 complete abstracts (674 words), 9 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Diagnosis of the type and, when feasible, the cause of a pathologic process by means of microscopic study of cells in an exudate or other form of body fluid. (Stedman, 26th ed)

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Cytodiagnoses.

Where it fits in the MeSH classification

Broader topics
Cytological Techniques
Narrower topics
Amniocentesis; Biopsy; Cytopathogenic Effect, Viral; Karyometry; Lymph Node Ratio

Research landscape

PubMed indexes 349,118 records tagged with the MeSH heading “Cytodiagnosis” (counts retrieved 2026-11-04). 44,087 of them (12.6%) were published from 2020 onward, and the busiest period so far is through 1999 with 134,580 records.

Reviews account for 34,906 records (10.0%) and meta-analyses for 1,665. Randomized controlled trials number 5,377 (1.5%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 134,580 records; 2000-2009: 73,614 records; 2010-2019: 96,837 records; 2020 onward: 44,087 records134,580through 199973,6142000-200996,8372010-201944,0872020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 1999134,580
2000-200973,614
2010-201996,837
2020 onward44,087
Share of records by publication typeReviews: 10.0 percent; Meta-analyses: 0.5 percent; Randomized controlled trials: 1.5 percentReviews10.0% (34,906)Meta-analyses0.5% (1,665)Randomized controlled trials1.5% (5,377)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 349,118 PubMed records
TypeRecordsShare
Reviews34,90610.0%
Meta-analyses1,6650.5%
Randomized controlled trials5,3771.5%

Method: PubMed query "Cytodiagnosis"[MeSH Terms] with publication-type and date filters, retrieved 2026-11-04.

Reading the evidence in diagnostics and medical technology

A test or device is judged by how well it detects a condition, how often it gives false alarms or misses cases, and whether using it improves outcomes for people. Accuracy depends on who is tested and how common the condition is, so a test that performs well in a specialist hospital can perform differently in the community. Check the reference standard, the population studied, the sensitivity and specificity and whether results were confirmed in a separate group.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Axillary Nodal Positivity in Early-Stage Invasive Lobular Carcinoma: Implications for Sentinel Lymph Node Biopsy Omission
Scardina L, D'Archi S, Accetta C, Carnassale B, Di Leone A, De Lauretis F, et al.
2026Research article
Design not recorded in structured metadata
5cc by
PMID 41817936 · DOI · PMC13179177
Clinical-grade autonomous cytopathology through whole-slide edge tomography
Nitta N, Sugiyama Y, Sugimura T, Ito T, Ikebata K, Abe H, et al.
2026Research article
Design not recorded in structured metadata
2cc by
PMID 41708854 · DOI · PMC12979202
Association between cervical conization and pregnancy outcomes: A nationwide population-based cohort study
Kim WJ, Kim YW
2026Research article
Design not recorded in structured metadata
1cc by
PMID 41701707 · DOI · PMC12912565

Axillary Nodal Positivity in Early-Stage Invasive Lobular Carcinoma: Implications for Sentinel Lymph Node Biopsy Omission [1]

Research article Scardina L, D'Archi S, Accetta C, Carnassale B, Di Leone A, De Lauretis F, et al. · · 2026 · cited 5 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Background Recent trials suggest omission of sentinel lymph node biopsy (SLNB) for selected early-stage breast cancer patients.
Closing excerpt
Pending evidence from prospective studies specifically designed for lobular histology, SLNB should continue to be considered an essential component of axillary evaluation in this subgroup.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (259 words)

Background Recent trials suggest omission of sentinel lymph node biopsy (SLNB) for selected early-stage breast cancer patients. However, invasive lobular carcinoma (ILC) is underrepresented, and retrospective data indicate higher rates of nodal metastases, raising concerns about axillary understaging. This study aimed to evaluate the prevalence and predictors of nodal metastases in early-stage, clinically node-negative ILC.Methods This study retrospectively analyzed 491 patients with estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative, clinical T1, clinically node-negative ILC who underwent breast-conserving surgery at our institution between 2004 and 2024. The exclusion criteria ruled out neoadjuvant therapy, tumor larger than 2 cm, and metastatic disease at diagnosis or prior breast cancer.Results Among 491 patients, 392 (79.8 %) were pN0, whereas 99 (20.2 %) had nodal metastases (pN1mi-pN3). Pathologic tumor size was significantly associated with axillary nodal involvement (p = 0.004). In contrast, histologic subtype was not significantly associated with nodal status (p = 0.15), although pleomorphic tumors demonstrated numerically higher rates of nodal involvement than classic invasive lobular carcinoma. Menopausal status was not predictive of nodal positivity (p = 0.96).Conclusions Approximately one (20.2 %) in five patients with early-stage, clinically node-negative ILC harbors occult axillary nodal metastases. Pathologic tumor size emerged as the primary determinant of nodal involvement. Pleomorphic variants showed a tendency toward higher nodal burden. These findings indicate that omission of SLNB in ILC may carry a risk of axillary understaging with potential therapeutic implications. Pending evidence from prospective studies specifically designed for lobular histology, SLNB should continue to be considered an essential component of axillary evaluation in this subgroup.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41817936 · DOI · PMC13179177

Clinical-grade autonomous cytopathology through whole-slide edge tomography [2]

Research article Nitta N, Sugiyama Y, Sugimura T, Ito T, Ikebata K, Abe H, et al. · · 2026 · cited 2 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Cytopathology, often abbreviated as cytology, has a central role in the early detection of cancer, such as cervical, lung and bladder cancers, owing to its speed, simplicity and minimally invasive nature1-9.
Closing excerpt
The system enables autonomous triage cytology, offering a foundation for routine, scalable and objective diagnostics.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (241 words)

Cytopathology, often abbreviated as cytology, has a central role in the early detection of cancer, such as cervical, lung and bladder cancers, owing to its speed, simplicity and minimally invasive nature1-9. However, its effectiveness is limited by variability in diagnostic accuracy stemming from subjective visual interpretation10-21. Although many artificial intelligence (AI)-powered systems have been proposed to improve consistency22-26, none have achieved fully autonomous, clinical-grade performance. Existing approaches serve as assistive tools and still rely on human oversight for interpretation and decision-making22-26. Here we present a clinical-grade autonomous cytopathology pipeline that combines high-resolution, real-time optical whole-slide tomography with edge computing to deliver end-to-end automation. The system achieves practical performance in imaging speed, quality and data volume, with localized data compression enabling streamlined storage and accelerated AI-driven analysis. In addition to supporting cell-level classification, the platform enables flow cytometry-like, population-wide morphological profiling for comprehensive interpretation of cellular distributions and patterns. A vision transformer achieved area under the receiver operating characteristic (ROC) curve (AUC) values exceeding 0.99 at the single-cell level for detecting low-grade squamous intraepithelial lesions (LSILs), high-grade squamous intraepithelial lesions (HSILs) and adenocarcinoma. In a multicentre evaluation of 1,124 cervical liquid-based cytology samples across four centres, the AI model achieved slide-level AUC values of 0.86-0.91 for LSIL+ and 0.89-0.97 for HSIL+, with LSIL counts correlating strongly with human papillomavirus positivity and HSIL counts scaling with diagnostic severity. The system enables autonomous triage cytology, offering a foundation for routine, scalable and objective diagnostics.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41708854 · DOI · PMC12979202

Association between cervical conization and pregnancy outcomes: A nationwide population-based cohort study [3]

Research article Kim WJ, Kim YW · · 2026 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Cervical conization is the standard treatment for cervical intraepithelial neoplasia.
Closing excerpt
The results point to a heightened obstetric risk following cervical conization, emphasizing the need for tailored prenatal care and continued prospective investigation.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (174 words)

Cervical conization is the standard treatment for cervical intraepithelial neoplasia. However, its effects on pregnancy outcomes remain controversial. Using data from the Korean National Health Insurance System, this population-based retrospective cohort study evaluated the relationship between cervical conization and adverse pregnancy outcomes between 2006 and 2022. Altogether, 199,826 singleton primiparous women aged 19 years or older were included, of whom 18,602 had undergone conization prior to pregnancy. The adjusted odds ratios for obstetric complications were estimated using multivariable logistic regression. Conization was associated with an elevated risk of cervical incompetence (adjusted odds ratios [aOR] 3.15; 95% confidence interval [CI] 3.01-3.30), preterm labor (aOR 1.44), preterm premature rupture of membranes (aOR 1.67), placenta previa, gestational diabetes, and intrauterine growth restriction. The subgroup analysis revealed that women who underwent both conization and cerclage had substantially higher risks of preterm labor and preterm premature rupture of membranes than did those who did not receive cerclage. The results point to a heightened obstetric risk following cervical conization, emphasizing the need for tailored prenatal care and continued prospective investigation.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41701707 · DOI · PMC12912565

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Complication rates of CT-guided transthoracic lung biopsy: meta-analysis [4]
    Heerink WJ, de Bock GH, de Jonge GJ, Groen HJ, Vliegenthart R, Oudkerk M · Eur Radiol · 2017 · cited 557 times (Europe PMC)
  • Research article Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis [5]
    Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F · Ultrasound Obstet Gynecol · 2015 · cited 430 times (Europe PMC)
  • Research article Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy [6]
    Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, Norrie J, et al. · Eur Urol · 2016 · cited 409 times (Europe PMC)
  • Research article Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis [7]
    Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, et al. · BMJ · 2016 · cited 333 times (Europe PMC)
  • Research article Screening for cervical cancer: a systematic review and meta-analysis [8]
    Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R · Syst Rev · 2013 · cited 298 times (Europe PMC)
  • Research article Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials [9]
    Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M · Eur J Cancer · 2015 · cited 247 times (Europe PMC)

References

  1. Scardina L, D'Archi S, Accetta C, Carnassale B, Di Leone A, De Lauretis F, et al.. Axillary Nodal Positivity in Early-Stage Invasive Lobular Carcinoma: Implications for Sentinel Lymph Node Biopsy Omission. . 2026. PMID 41817936 · DOI · PMC13179177
  2. Nitta N, Sugiyama Y, Sugimura T, Ito T, Ikebata K, Abe H, et al.. Clinical-grade autonomous cytopathology through whole-slide edge tomography. . 2026. PMID 41708854 · DOI · PMC12979202
  3. Kim WJ, Kim YW. Association between cervical conization and pregnancy outcomes: A nationwide population-based cohort study. . 2026. PMID 41701707 · DOI · PMC12912565
  4. Heerink WJ, de Bock GH, de Jonge GJ, Groen HJ, Vliegenthart R, Oudkerk M. Complication rates of CT-guided transthoracic lung biopsy: meta-analysis. Eur Radiol. 2017. PMID 27108299 · DOI · PMC5127875
  5. Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015. PMID 25042845 · DOI
  6. Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, Norrie J, et al.. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol. 2016. PMID 26323946 · DOI
  7. Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, et al.. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016. PMID 27469988 · DOI · PMC4964801
  8. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013. PMID 23706117 · DOI · PMC3681632
  9. Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer. 2015. PMID 26296294 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-11-04; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-11-04.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Liquid BiopsyDiagnostics and Medical Technology
  • Flow CytometryDiagnostics and Medical Technology
  • Freeze DryingDiagnostics and Medical Technology
  • Tissue PreservationDiagnostics and Medical Technology
  • Blood Cell CountMolecular Biology
  • CD4-CD8 RatioImmunology

All 110 articles in Diagnostics and Medical Technology →

At a glance

349,118
PubMed records on this heading
13%
published since 2020
34,906
review articles
5,377
randomized trials
9
verified references below

Counts come from PubMed on 2026-11-04; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Liquid BiopsyDiagnostics and Medical Technology
  • Flow CytometryDiagnostics and Medical Technology
  • Freeze DryingDiagnostics and Medical Technology
  • Tissue PreservationDiagnostics and Medical Technology
  • Blood Cell CountMolecular Biology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support